Free Trial

Short Interest in Nature's Sunshine Products, Inc. (NASDAQ:NATR) Drops By 19.2%

Nature's Sunshine Products logo with Medical background

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 59,800 shares, a decline of 19.2% from the March 15th total of 74,000 shares. Based on an average daily volume of 37,000 shares, the short-interest ratio is presently 1.6 days. Currently, 0.4% of the company's shares are short sold.

Analyst Ratings Changes

Separately, DA Davidson upgraded Nature's Sunshine Products to a "strong-buy" rating in a research report on Monday, April 14th.

View Our Latest Stock Analysis on NATR

Institutional Trading of Nature's Sunshine Products

Several large investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its holdings in shares of Nature's Sunshine Products by 2,090.2% during the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after buying an additional 2,132 shares in the last quarter. Russell Investments Group Ltd. purchased a new position in Nature's Sunshine Products during the 4th quarter valued at about $41,000. Amundi acquired a new position in shares of Nature's Sunshine Products in the 4th quarter valued at about $63,000. Deutsche Bank AG purchased a new stake in shares of Nature's Sunshine Products in the fourth quarter worth approximately $103,000. Finally, Wells Fargo & Company MN boosted its holdings in shares of Nature's Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock worth $106,000 after purchasing an additional 1,611 shares during the period. 79.40% of the stock is owned by institutional investors and hedge funds.

Nature's Sunshine Products Stock Performance

Shares of NASDAQ:NATR traded down $0.07 during mid-day trading on Friday, hitting $11.46. The stock had a trading volume of 60,940 shares, compared to its average volume of 48,801. The company's 50 day moving average is $12.92 and its 200-day moving average is $14.08. Nature's Sunshine Products has a 12-month low of $10.81 and a 12-month high of $19.92. The company has a market cap of $211.83 million, a PE ratio of 13.02 and a beta of 1.06.

Nature's Sunshine Products Company Profile

(Get Free Report)

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

See Also

Should You Invest $1,000 in Nature's Sunshine Products Right Now?

Before you consider Nature's Sunshine Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.

While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines